EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

On the regulation of human D‐aspartate oxidase

Valentina Rabattoni, Zoraide Motta, Matteo Miceli, Gianluca Molla, Alex Fissore, Salvatore Adinolfi, Loredano Pollegioni, Silvia Sacchi iD

Protein Science · 2023-11 · 32 (11)

DOI: 10.1002/pro.4802 ↗

At a glance

Journal article in Protein Science, published online on 2023-10-20. Written by Valentina Rabattoni and 7 co-authors. Institution: "The Protein Factory 2.0", Dipartimento di Biotecnologie e Scienze della Vita, Università degli studi dell'Insubria, Varese, Italy. Major MEDLINE topics: Oxidoreductases, Schizophrenia. Cited 9 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: University of Insubria.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The human flavoenzyme D‐aspartate oxidase (hDASPO) controls the level of D‐aspartate in the brain, a molecule acting as an agonist of NMDA receptors and modulator of AMPA and mGlu5 receptors. hDASPO‐induced D‐aspartate degradation prevents age‐dependent deterioration of brain functions and is related to psychiatric disorders such as schizophrenia and autism. Notwithstanding this crucial role, less is known about hDASPO regulation. Here, we report that hDASPO is nitrosylated in vitro , while no evidence of sulfhydration and phosphorylation is apparent: nitrosylation affects the activity of the human flavoenzyme to a limited extent. Furthermore, hDASPO interacts with the primate‐specific protein pLG72 (a well‐known negative chaperone of D‐amino acid oxidase, the enzyme deputed to D‐serine degradation in the human brain), yielding a ~114 kDa complex, with a micromolar dissociation constant, promoting the flavoenzyme inactivation. At the cellular level, pLG72 and hDASPO generate a cytosolic complex: the expression of pLG72 negatively affects the hDASPO level by reducing its half‐life. We propose that pLG72 binding may represent a protective mechanism aimed at avoiding cytotoxicity due to H 2 O 2 produced by the hDASPO enzymatic degradation of D‐aspartate, especially before the final targeting to peroxisomes.

Subjects

MeSH terms (MEDLINE)

OxidoreductasesSchizophreniaAnimalsHumansD-Aspartate OxidaseD-Aspartic AcidCarrier Proteins

Author keywords

D-aspartateflavooxidaseneurotransmissionpLG72post-translational modificationprotein-protein interaction

Substances

OxidoreductasesD-Aspartate OxidaseD-Aspartic AcidCarrier Proteins

Authors and institutions

  • "The Protein Factory 2.0", Dipartimento di Biotecnologie e Scienze della Vita, Università degli studi dell'Insubria, Varese, Italy.
  • Dipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, Torino, Italy.

ORCID profiles: Silvia Sacchi

Funding

  • University of Insubria

Cite

APA

Rabattoni, V., Motta, Z., Miceli, M., Molla, G., Fissore, A., Adinolfi, S., Pollegioni, L., & Sacchi, S. (2023). On the regulation of human D‐aspartate oxidase. Protein Science, 32(11). https://doi.org/10.1002/pro.4802

Vancouver

Rabattoni V, Motta Z, Miceli M, Molla G, Fissore A, Adinolfi S, et al. On the regulation of human D‐aspartate oxidase. Protein Science. 2023;32(11). doi:10.1002/pro.4802

BibTeX
@article{Rabattoni2023,
  author = {Rabattoni, Valentina and Motta, Zoraide and Miceli, Matteo and Molla, Gianluca and Fissore, Alex and Adinolfi, Salvatore and Pollegioni, Loredano and Sacchi, Silvia},
  title = {On the regulation of human D‐aspartate oxidase},
  journal = {Protein Science},
  year = {2023},
  volume = {32},
  number = {11},
  doi = {10.1002/pro.4802}
}
Start for free →